Confirm RX
Device Cardiac Rhythm Management
PDI 05415067027320
General payments
$1,040,318
Research payments
$2,312,517
Through program year 2025, $1,040,318 in general payments and $2,312,517 in research payments were reported against Confirm RX (Cardiac Rhythm Management).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $329,089 | 11 |
| 2024 | General | $68,477 | 667 |
| 2024 | Research | $142,768 | 20 |
| 2023 | General | $77,053 | 1,941 |
| 2023 | Research | $789,460 | 45 |
| 2022 | General | $369,875 | 8,683 |
| 2022 | Research | $108,548 | 97 |
| 2021 | General | $524,913 | 11,200 |
| 2021 | Research | $942,652 | 121 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 35 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
22,491 general · 294 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.